| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药工业(元) | 1,228,695,224.11 | 2,292,985,290.86 | 1,639,581,705.25 |
| 医药商业(元) | 33,297,654.36 | 69,964,909.46 | 34,369,615.64 |
| 营业成本(元) | |||
| 医药工业(元) | 501,316,366.06 | 934,578,423.15 | 676,199,073.85 |
| 医药商业(元) | 11,864,767.85 | 32,416,087.91 | 14,988,692.93 |
| 毛利(元) | |||
| 医药工业(元) | 727,378,858.05 | 1,358,406,867.71 | 963,382,631.40 |
| 医药商业(元) | 21,432,886.51 | 37,548,821.55 | 19,380,922.71 |
| 毛利率(%) | |||
| 医药工业(%) | 59.20 | 59.24 | 58.76 |
| 医药商业(%) | 64.37 | 53.67 | 56.39 |
| 收入构成(%) | |||
| 医药工业(%) | 97.36 | 97.04 | 97.95 |
| 医药商业(%) | 2.64 | 2.96 | 2.05 |
| 毛利构成(%) | |||
| 医药工业(%) | 97.14 | 97.31 | 98.03 |
| 医药商业(%) | 2.86 | 2.69 | 1.97 |